Wheeze Detection Using Aevice Medical Device

Launched by AEVICE HEALTH PTE. LTD. · Jan 4, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a device made by Aevice Medical that aims to detect wheezing in patients as accurately as a doctor can using a stethoscope. Wheezing is a whistling sound that happens when breathing, often related to conditions like asthma or chronic obstructive pulmonary disease (COPD). The trial will also explore whether this device can help doctors listen to patients' lung sounds remotely, which could be helpful for those who cannot visit a clinic easily.

To participate in this study, children and teenagers aged 3 to 18 who have wheezing symptoms may be eligible, provided they and their parents can agree to take part. Participants will undergo assessments with the Aevice device, and their results will be compared to those from a physician's examination. It's important to note that individuals with other serious health issues may not be eligible for this study to ensure their safety. Overall, this trial could lead to improved ways of monitoring wheezing and managing respiratory conditions in young patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The subject is willing and parents/guardians are able to give informed consent for participation in the study.
• • Male or Female, aged 3 -18 years.
• • Presenting with wheeze.
• • Able (in the Investigators opinion) and willing to comply with all study requirements
• Exclusion Criteria:
• • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.